Get Connected:

 

Latest News

Trending News Today: Americans Face Price Increases, Few Options in ACA Marketplaces
Top news of the day from across the healthcare landscape.
Glycopyrrolate inhalation solution is the first nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease.
Institute for Safe Medication Practices releases annual review of the year’s biggest medication safety issues. 
Top articles of the week from The American Journal of Pharmacy Benefits.
Diabetics using continuous glucose monitors were more aware of their blood sugar levels.
Top news of the day from across the healthcare landscape.
A look at last week's top stories in the world of pharmacy.
Children with ADHD treated with AKL-T01 showed a significant positive improvement in attention.
View More >

From the Journals

Focusing on cost alone could diminish the vital service aspects behind successfully caring for a patient in a specialty pharmacy.
In a review of publicly reported diabetes quality measures for Medicaid fee-for-service, overall reporting was low and reports of outcomes measures were rarely available.
This study assessed the impact of initiating hyaluronic acid injections on pain management pharmacotherapies utilization patterns in patients with knee osteoarthritis.
Initiation of treatment with guideline-recommended medications within 60 days of fibromyalgia diagnosis was associated with immediate annual healthcare cost savings.
The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Many healthcare stakeholders are concerned that pharmacy benefit managers use perverse incentives that work against healthcare goals, such as improved outcomes and lower costs.
For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Upcoming Partner Events